With the analysis among 2,427 patents, we discovered top 460 key players by total patent application. Genentech, Inc., F. Hoffmann-La Roche Ltd., Immatics Biotechnologies GmbH are dominant in this area. They take 9.68% of the total patent filing.
California, United States
Patent: 83
F. Hoffmann-La Roche Ltd.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 70
Basel-Stadt, Switzerland
Patent: 64
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 57
Hessen, Germany
Patent: 56
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 45
California, United States
Patent: 41
New York, United States
Patent: 38
Indiana, United States
Patent: 35
With the analysis among 77 patents, we discovered top 22 start-ups by total patent application. ALX Oncology, Inc., Combined Therapeutics, Inc., Ervaxx Ltd. are active in this area.
California, United States
Patent: 15
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 10
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 8
OrigiMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 5
Illinois, United States
Patent: 2
California, United States
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 2
With the analysis among related 2,053 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Genentech, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. take 7.16% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 50
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 45
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 43
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 39
New York, United States
Patent: 30
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 26
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 25
Hessen, Germany
Patent: 25
With the analysis among related 2,053 patents in last 5 years, we discover 389 new entrants. Shenzhen Chipscreen Biosciences Co., Ltd., Iovance Biotherapeutics, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd. are the most active new entrants in this area.
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 26
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 25
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 20
California, United States
Patent: 15
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
Shanghai Shi, China
Patent: 15
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 13
New York, United States
Patent: 13
Hovedstaden, Denmark
Patent: 13
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 12
With the analysis among 819 patents, we discovered top 203 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of British Columbia, Cornell University are dominant in this area. They take 6.59% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 17
University of British Columbia
British Columbia, Canada
Patent: 15
New York, United States
Patent: 13
Guangdong Sheng, China
Patent: 12
Sichuan Sheng, China
Patent: 12
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 12
Zhejiang Sheng, China
Patent: 12
Shanghai Shi, China
Patent: 12
Shanghai Shi, China
Patent: 11
Guangdong Sheng, China
Patent: 10